Testing sivelestat sodium for heart bypass patients
Part of Heart & circulation clinical trials.
This trial tests if an anti-inflammatory drug called sivelestat sodium can help people recover after heart bypass surgery. It is for patients having planned bypass surgery on at least two heart arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having planned heart bypass surgery (off-pump) on at least two blood vessels.
- Your heart pumps at least 35% of blood out each beat (LVEF 35% or higher).
- Your liver and kidneys are working well enough (certain lab tests are within limits).
- You have not taken strong anti-inflammatory drugs or immune-suppressing medicines in the last 30 days.
- You do not have an active infection, an autoimmune disease, or a history of allergies to the study drug.
- You are not having an emergency surgery or a procedure that also fixes a heart valve or the main artery from the heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called a PCSK9 inhibitor can reduce harmful inflammation and organ damage in people recovering from coronary artery bypass surgery (CABG). If you are scheduled for bypass surgery within a month, this study may be an option for you.
This trial tests if dexmedetomidine or methylprednisolone is better at reducing inflammation during coronary artery bypass grafting (CABG) with a heart-lung machine. The goal is to find a treatment that helps patients recover better.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This study looks at whether giving dexamethasone and olanzapine during certain heart surgeries can improve how blood flow and ventilation (breathing support) are managed. It’s meant to see if these medicines help the body handle heart-lung bypass more safely.
This trial tests whether a medication called vericiguat, given around the time of heart surgery, can help protect your heart and prevent heart failure complications. You'll receive the study drug or a placebo before and after surgery and be monitored for 6 months.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.